… proteins (CSF) for many years, having undertaken a PhD into the use of cerebrospinal fluid (CSF) proteins in the diagnosis of dementia at The Institute of Neurology, … she moved to the National Creutzfeldt-Jakob disease (CJD) Research & Surveillance Unit, University of Edinburgh to …

… are doing approximately seven to eight years after diagnosis. Some patients have few symptoms at this time, … pattern of symptoms seven to eight years after diagnosis. Early identification of patients who are anticipated to … and specific subtypes of patients may be selected for entry into clinical trials designed to evaluate therapies to …

… on behalf of The Michael J. Fox Foundation and AbbVie in early 2014 found significant knowledge gaps among people … to for support or information. This knowledge gap extends into patients’ awareness about specialty care for their … more informed about basic issues in managing PD, including diagnosis (89 percent of patients who see a movement …

… in PD, we could potentially consolidate different lines of research on Kv1.3 and NLRP3 inflammasome signaling mechanisms into a single multi-pronged therapeutic approach to PD pathology with implications for early diagnosis and prevention.   Next Steps for …

… Parkinson’s disease (PD) will be altered at specific sites compared to either healthy controls or to Alzheimer’s … post-mortem or agonal artifacts. We will determine significant methylation differences between all groups on a … sites for all patients profiled. This data will then be used to determine if altered DNA methylation may be …

… (PD) in these populations, which are underrepresented in research, we anticipate that we can reduce existing health … Steps for Development: This model can be adopted by other researchers and health professionals to direct the … Diversity, Equity and Inclusivity in Parkinson's research …